Diar

Diar500 mg

Tablet

Nitazoxanide

ACI Limited

Product Code : 4889
MRP 10.07
10% Off
Best PriceTk
/
1
Section

Alternatives

See All
Product Image
10% Off

Zox500 mg

Nitazoxanide

Square Pharmaceuticals Ltd.

9.06
10.07
Add to cart
Product Image
10% Off

Nitazox500 mg

Nitazoxanide

Incepta Pharmaceuticals Ltd.

9.00
10.00
Add to cart
Product Image
10% Off

Alinix500 mg

Nitazoxanide

Healthcare Pharmacuticals Ltd.

9.00
10.00
Out Of Stock
Product Image
10% Off

Nidozox500 mg

Nitazoxanide

ACME Laboratories Ltd.

9.06
10.07
Add to cart
Product Image
10% Off

Nitoxin500 mg

Nitazoxanide

Aristopharma Ltd.

9.00
10.00
Add to cart
Product Image
10% Off

Atinid500 mg

Nitazoxanide

Biopharma Laboratories Ltd.

9.06
10.07
Add to cart
Product Image
10% Off

Dianide500 mg

Nitazoxanide

General Pharmaceuticals Ltd.

9.06
10.07
Add to cart
Product Image
10% Off

Nidor500 mg

Nitazoxanide

Pharmasia Limited

9.04
10.04
Out Of Stock
Product Image
10% Off

Nitanid500 mg

Nitazoxanide

Drug International Ltd.

9.05
10.05
Add to cart
Product Image
10% Off

Nitasol500 mg

Nitazoxanide

Ibn-Sina Pharmaceuticals Ltd.

9.91
11.01
Add to cart
Product Image
10% Off

Nitax500 mg

Nitazoxanide

Delta Pharma Ltd.

8.10
9.00
Add to cart
Product Image
10% Off

Nitide500 mg

Nitazoxanide

NIPRO JMI Pharma Ltd.

9.03
10.03
Add to cart
Product Image
10% Off

Toza500 mg

Nitazoxanide

Eskayef Bangladesh Ltd.

9.00
10.00
Add to cart
Product Image
10% Off

Xanide500 mg

Nitazoxanide

Globe Pharmaceuticals Ltd.

9.00
10.00
Add to cart
Product Image
10% Off

Xanita500 mg

Nitazoxanide

Renata Limited

9.04
10.04
Add to cart
Product Image
10% Off

Zoana500 mg

Nitazoxanide

Orion Pharma Ltd.

9.06
10.07
Add to cart
Product Image
10% Off

Zoxan500 mg

Nitazoxanide

Opsonin Pharma Ltd.

9.06
10.07
Add to cart
Section

Medicine overview

Indications of Diar 500 mg

Diar 500 mg is indicated for the treatment of diarrhea caused by Cryptosporidium parvum, Giardia lamblia and Entamoeba histolytica.

Theropeutic Class

Anti-diarrhoeal Antiprotozoal

Pharmacology

Diar 500 mg is a synthetic antiprotozoal agent for oral administration. The antiprotozoal activity of Diar 500 mg is believed to be interference with the Pyruvate Ferredoxin Oxido Reductase (PFOR) enzyme-dependant electron transfer reaction. This reaction is essential for anaerobic energy metabolism of the protozoa. Diar 500 mg and its metabolites, tizoxanid are active in vitro in inhibiting the growth of sporozoites and oocyst of Cryptosporidium parvum and trophozoites of Giardia lamblia.

Dosage & Administration of Diar 500 mg

Age 1-3 years: 1 tea-spoonfull or 5 ml suspension every 12 hours for 3 days. Age 4-11 years: 2 tea-spoonfulls or 10 ml suspension every 12 hours for 3 days.Age 12 years or above: 5 tea-spoonfulls (25 ml) suspension or 1 tablet every 12 hours for 3 days. It is recommended to be administered with food.

Dosage of Diar 500 mg

Age 1-3 years: 1 tea-spoonfull or 5 ml suspension every 12 hours for 3 days. Age 4-11 years: 2 tea-spoonfulls or 10 ml suspension every 12 hours for 3 days.Age 12 years or above: 5 tea-spoonfulls (25 ml) suspension or 1 tablet every 12 hours for 3 days. It is recommended to be administered with food.

Interaction of Diar 500 mg

It is highly bound to plasma protein. Therefore, caution should be exercised when administering Diar 500 mg concurrently with other highly plasma protein-bound drugs with narrow therapeutic index.

Contraindications

It is contraindicated in patients with known hypersensitivity to Diar 500 mg or any components of the preparation.

Side Effects of Diar 500 mg

The most frequent side effects, reported by Diar 500 mg are abdominal pain, vomiting and headache. These side effects are typically mild and transient in nature. Very rare side effects include- nausea, anorexia, flatulence, increased appetite, enlarged salivary glands, increased creatinine & SGPT level, pruritus, rhinitis, sweating, dizziness, discolored urine etc.

Pregnancy & Lactation

US FDA pregnancy category of Diar 500 mg is B. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. Diar 500 mg have been shown to be excreted in human milk. So, caution should be exercised when Diar 500 mg is administered during lactation.

Precautions & Warnings

Diar 500 mg must be administered with caution to patients with hepatic & biliary disease and to patients with renal disease.

Storage Conditions

Keep in a dry place away from light and heat. Keep out of the reach of children.

Drug Classes

Anti-diarrhoeal Antiprotozoal

Mode Of Action

Diar 500 mg is a synthetic antiprotozoal agent for oral administration. The antiprotozoal activity of Diar 500 mg is believed to be interference with the Pyruvate Ferredoxin Oxido Reductase (PFOR) enzyme-dependant electron transfer reaction. This reaction is essential for anaerobic energy metabolism of the protozoa. Diar 500 mg and its metabolites, tizoxanid are active in vitro in inhibiting the growth of sporozoites and oocyst of Cryptosporidium parvum and trophozoites of Giardia lamblia.

Pregnancy

US FDA pregnancy category of Diar 500 mg is B. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. Diar 500 mg have been shown to be excreted in human milk. So, caution should be exercised when Diar 500 mg is administered during lactation.
Disclaimer

The information provided is accurate to our best practices, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy. The absence of specific information about a drug should not be seen as an endorsement. We are not responsible for any consequences resulting from this information, so consult a healthcare professional for any concerns or questions.